In a report released today, Mohan Naidu from Oppenheimer maintained a Buy rating on Hms Holdings Corp (NASDAQ: HMSY), with a price target of $30. The company’s shares opened today at $27.15, close to its 52-week high of $28.69.
Naidu commented:
“HMSY’s Q2:19 numbers beat our/consensus estimates handily at $147M/$0.25 (vs. consensus $139M/$0.19). Broad-based strength across state and commercial segments, especially in the care mgmt and consumer engagement solutions, lifted numbers. Eliza continued its strength with ~80% y/y growth, and mgmt. underscored pipeline strength. After initial hiccups, we believe the expansion into Care mgmt. and consumer engagement offerings is starting to yield results for HMS. Additionally, HMSY launched the Elli offering that consolidates data from disparate sources to create comprehensive member profiles that can deliver great insights into the member at enrollment, which can be valuable in addressing utilization and improving care coordination. We believe we are starting to see benefits of HMSY’s data sources and monetization opportunities. Reiterate Outperform, increasing target to $30 from $23.”
According to TipRanks.com, Naidu is a 5-star analyst with an average return of 13.1% and a 60.4% success rate. Naidu covers the Services sector, focusing on stocks such as Tivity Health Inc, Express Scripts, and Evolent Health.
Hms Holdings Corp has an analyst consensus of Moderate Buy, with a price target consensus of $23.
See today’s analyst top recommended stocks >>
The company has a one-year high of $28.69 and a one-year low of $11.01. Currently, Hms Holdings Corp has an average volume of 439.9K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. The firm operates through its wholly owned subsidiaries, Health Management Systems, Inc. HealthDataInsights, Inc., HMS Care Analytics, Inc., IntegriGuard, LLC, and Reimbursement Services Group Inc..
